Similar articles

• Invited commentary: condom effectiveness-will prostate-specific antigen shed new light on this perplexing problem?

  Steiner MJ, Feldblum PJ, Padian N. Steiner MJ, et al. Am J Epidemiol. 2003 Feb 15;157(4):298-300; discussion 301-2. doi: 10.1093/aje/kwf213. Am J Epidemiol. 2003. PMID: 12578799 No abstract available.
• Efficacy of the female condom as a barrier to semen during intercourse.

  Macaluso M, Lawson ML, Hortin G, Duerr A, Hammond KR, Blackwell R, Bloom A. Macaluso M, et al. Am J Epidemiol. 2003 Feb 15;157(4):289-97. doi: 10.1093/aje/kwf212. Am J Epidemiol. 2003. PMID: 12578798
• Partner characteristics, intensity of the intercourse, and semen exposure during use of the female condom.

  Lawson ML, Macaluso M, Duerr A, Hortin G, Hammond KR, Blackwell R, Artz L, Bloom A. Lawson ML, et al. Am J Epidemiol. 2003 Feb 15;157(4):282-8. doi: 10.1093/aje/kwf211. Am J Epidemiol. 2003. PMID: 12578797
• Biomarkers of semen in the vagina: applications in clinical trials of contraception and prevention of sexually transmitted pathogens including HIV.

  Mauck CK, Doncel GF; Biomarkers of Semen Exposure Clinical Working Group. Mauck CK, et al. Contraception. 2007 Jun;75(6):407-19. doi: 10.1016/j.contraception.2007.02.007. Epub 2007 Apr 30. Contraception. 2007. PMID: 17519146 Review.
• Promoting protection and pleasure: amplifying the effectiveness of barriers against sexually transmitted infections and pregnancy.

  Philpott A, Knerr W, Maher D. Philpott A, et al. Lancet. 2006 Dec 2;368(9551):2028-31. doi: 10.1016/S0140-6736(06)69810-3. Lancet. 2006. PMID: 17141710 Review. No abstract available.